Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Meta Biomed has launched its new product BoneMedik-S and BoneMedik-DM, a biocompatible bone graft substitute based on natural coral.
Subscribe to our email newsletter
The company said that, FDA approved and US patented, its natural coral based hydroxyapatite provides framework to promote strong and faster regeneration and healing. It is of the highest product quality and most compatible with the human bone structure, the company added.
The company has been working with the Pennsylvania State University for clinical monitoring and research on its bone products under agreement. For BoneMedik-S and BoneMedik-DM, the company said that it is looking for strategic partnerships to penetrate into the US and global market.
Seungwoo Song, managing director of operations at Meta Biomed, said: “Our company’s motto is to envision the future with diamond quality, gold service and silver prices. Promoting an excellent product at competitive prices is the key to a great future for this company.”